Skip to main navigation Skip to search Skip to main content

p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

  • Nick Carpino
  • , David Wisniewski
  • , Annabel Strife
  • , Daniel Marshak
  • , Ryuji Kobayashi
  • , Bruce Stillman
  • , Bayard Clarkson
  • Memorial Sloan-Kettering Cancer Center
  • Cold Spring Harbor Laboratory
  • Osiris Therapeutics, Inc.
  • Johns Hopkins University
  • Stony Brook University

Research output: Contribution to journalArticlepeer-review

355 Scopus citations

Abstract

Characteristic of chronic myelogenous leukemia (CML) is the presence of the chimeric p210(bcr-abl) protein possessing elevated protein tyrosine kinase activity relative to normal c-abl tyrosine kinase. Hematopoietic progenitors isolated from CML patients in the chronic phase contain a constitutively tyrosine-phosphorylated protein that migrates at 62 kDa by SDS-PAGE and associates with the p120 ras GTPase-activating protein (GAP). We have purified p62(dok) from a hematopoietic cell line expressing p210(bcr- abl). p62(dok) is a novel protein with features of a signaling molecule. Association of p62(dok) with GAP correlates with its tyrosine phosphorylation. p62(dok) is rapidly tyrosine-phosphorylated upon activation of the c-Kit receptor, implicating it as a component of a signal transduction pathway downstream of receptor tyrosine kinases.

Original languageEnglish
Pages (from-to)197-204
Number of pages8
JournalCell
Volume88
Issue number2
DOIs
StatePublished - Jan 24 1997

Fingerprint

Dive into the research topics of 'p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells'. Together they form a unique fingerprint.

Cite this